| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.31 | 0.08 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |